MedTrace Logo

Risk and Protective Factors in Multimodal Pain Therapy in Patients With Chronic Lumbal Pain

NCT04881188 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-05-18

No results posted yet for this study

Summary

Results will show important information about potential protective factors which might be relevant for the recovery of patients suffering from low back pain (theoretical basis). On a clinically applied basis we plan the validation of a short screening in concerns of psychosocial risk and protective factors in patients with chronic low back pain undergoing a multimodal pain therapy (MPT), and this for the first time.

Three main aims are: 1. Prospective validation of a short screening on a theoretical basis for the collection of psychosocial risk factors concerning of an unfavourable therapeutic process in MPT. 2. the verification of differences in subgroups with regard to pain management on a basis of the Avoidance Endurance Model in the development of pain and pain-related disability. 3. The evaluation of potential psychosocial protective factors supporting a positive outcome of MPT, such as resilience, acceptance, self-compassion, and body image.

Conditions

  • Chronic Low-back Pain

Interventions

DIAGNOSTIC_TEST

Survey

Patients with chronic low back pain in in-patient multimodal pain therapy. Three survey times, questionnaires

Sponsors & Collaborators

  • Katholisches Klinikum Bochum

    collaborator UNKNOWN

  • Ruhr University of Bochum

    lead OTHER

Principal Investigators

  • Tobias L Schulte, Prof. · Katholisches Klinikum Bochum

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-31
Primary Completion
2023-12-31
Completion
2024-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04881188 on ClinicalTrials.gov